drugset / Trial / NCT04387617

A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones

NCT04387617

Phase 2/3 Completed 90 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of this study is to determine if CBD oil has any effect on decreasing postoperative pain control following ureteroscopy for urinary stone disease, and to determine if CBD oil has any effect in decreasing the amount of postoperative opioids (commonly used drug) used by patients after undergoing ureteroscopy for urinary stone disease.

Timeline

Start
2021-02-15
Primary completion
2022-01-31
Completion
2022-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 20 mg

Indications